Central regions | Finance, business | Technology & innovation

Advanced multiple myeloma drug candidate gets Russian backing

31 Oct '17
Primer Capital, a Russian biotech-focused VC fund, earlier this year supported the development of a drug candidate by Russian company Hemopharm to help multiple myeloma patients. The investment was to fund preclinical trials.

Multiple myeloma is a cancer of plasma cells. Initially, often no symptoms are noticed; but when advanced, bone pain, bleeding, frequent infections, and anemia may occur. Complications may include amyloidosis. Believed to be incurable, the disease stays with the patient for as long as he lives, and all physicians can do is increase his life expectancy and improve the quality of life. Drugs currently available in the market are known for high toxicity and low efficacy, which necessitates the development of low-toxicity target drugs to boost the patient’s resistance.

Primer Capital believes the new Hemopharm solution will evolve to be such a drug, as no direct competition is known to exist in the global pharmaceutical market. The candidate the fund has invested in is a humanized antibody with purportedly outstanding anti-tumor activity and low toxicity with proven in vivo efficacy.

“We expect preclinical trials to provide ample evidence to the high efficacy of the drug; if so, our fund will readily consider participating in the project’s next funding round to back the clinical trial stage. The effort has the potential to attract a lot of pharmas, and not only in Russia,” Primer Capital Executive Director Elizaveta Rozhdestvenskaya said in a comment on the deal.

Primer Capital invests primarily in pharmaceutical and biotech projects.
Publish in Twitter
Write to Facebook
Google Buzz
Write to LiveJournal
Show in MM
Share MK
COMMENT ON THIS STORY
Find Related Content

Locations:

Tags: investment (547) / Primer Capital (4) / multiple myeloma (0) / Hemopharm (0) /

Latest News: Central regions
21 Nov '17 | Finance, business | Technology & innovation
20 Nov '17 | Technology & innovation | Retail, FMCG
17 Nov '17 | Technology & innovation
15 Nov '17 | Technology & innovation | Finance, business
14 Nov '17 | Finance, business | Transport, logistics
 

Feature stories

21 Nov '17
Russian scientists have come up with what they say is...
7 Sep '17
26 Jul '17
Scientists at Tomsk Polytechnic (TPU) in Siberia have...
Search (News archive - 21194)
Advertising
Global_Entrepreneurship_Monitor
Advertising
Marchmont News

Latest News

21 Nov '17
Entrepreneurs who invest in start-ups may have their...
20 Nov '17
Moscow scientists have developed a cosmetic solution...
17 Nov '17
Three major Russian institutions—the Far East...

Most read stories from last week

20 Nov '17
Moscow scientists have developed a cosmetic solution...
21 Nov '17
Entrepreneurs who invest in start-ups may have their...
21 Nov '17
Russian scientists have come up with what they say is...